Phosphorylation Signaling in APP Processing in Alzheimer's Disease

被引:74
作者
Zhang, Tao [1 ]
Chen, Dongmei [1 ]
Lee, Tae Ho [1 ]
机构
[1] Fujian Med Univ, Sch Basic Med Sci, Inst Translat Med, Fujian Key Lab Translat Res Canc & Neurodegenerat, Fuzhou 350122, Peoples R China
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; APP processing; phosphorylation; amyloid-beta; kinase; AMYLOID PRECURSOR PROTEIN; ALPHA-CONVERTING-ENZYME; PROLYL ISOMERASE PIN1; GAMMA-SECRETASE; CYTOPLASMIC DOMAIN; ECTODOMAIN PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; NUCLEAR TRANSLOCATION; INTRACELLULAR DOMAIN; TERMINAL FRAGMENTS;
D O I
10.3390/ijms21010209
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The abnormal accumulation of amyloid-beta (A beta) in the central nervous system is a hallmark of Alzheimer's disease (AD). The regulation of the processing of the single- transmembrane amyloid precursor protein (APP) plays an important role in the generation of A beta in the brain. The phosphorylation of APP and key enzymes involved in the proteolytic processing of APP has been demonstrated to be critical for modulating the generation of A beta by either altering the subcellular localization of APP or changing the enzymatic activities of the secretases responsible for APP processing. In addition, the phosphorylation may also have an impact on the physiological function of these proteins. In this review, we summarize the kinases and signaling pathways that may participate in regulating the phosphorylation of APP and secretases and how this further affects the function and processing of APP and A beta pathology. We also discuss the potential of approaches that modulate these phosphorylation-signaling pathways or kinases as interventions for AD pathology.
引用
收藏
页数:22
相关论文
共 153 条
[1]   Phosphorylation of Amyloid Precursor Protein at Threonine 668 Is Essential for Its Copper-responsive Trafficking in SH-SY5Y Neuroblastoma Cells [J].
Acevedo, Karla M. ;
Opazo, Carlos M. ;
Norrish, David ;
Challis, Leesa M. ;
Li, Qiao-Xin ;
White, Anthony R. ;
Bush, Ashley I. ;
Camakaris, James .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (16) :11007-11019
[2]   DOWN-REGULATION OF AMYLOID PRECURSOR PROTEIN INHIBITS NEURITE OUTGROWTH IN-VITRO [J].
ALLINQUANT, B ;
HANTRAYE, P ;
MAILLEUX, P ;
MOYA, K ;
BOUILLOT, C ;
PROCHIANTZ, A .
JOURNAL OF CELL BIOLOGY, 1995, 128 (05) :919-927
[3]   A review on cholinesterase inhibitors for Alzheimer's disease [J].
Anand, Preet ;
Singh, Baldev .
ARCHIVES OF PHARMACAL RESEARCH, 2013, 36 (04) :375-399
[4]  
Ando K, 1999, J NEUROSCI, V19, P4421
[5]  
Aplin AE, 1996, J NEUROCHEM, V67, P699
[6]   Putative function of ADAM9, ADAM10, and ADAM17 as APP α-secretase [J].
Asai, M ;
Hattori, C ;
Szabó, B ;
Sasagawa, N ;
Maruyama, K ;
Tanuma, S ;
Ishiura, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 301 (01) :231-235
[7]   Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review [J].
Avgerinos, Konstantinos Ioannis ;
Kalaitzidis, Grigorios ;
Malli, Antonia ;
Kalaitzoglou, Dimitrios ;
Myserlis, Pavlos Gr. ;
Lioutas, Vasileios-Arsenios .
JOURNAL OF NEUROLOGY, 2018, 265 (07) :1497-1510
[8]   From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery [J].
Banks, William A. .
NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (04) :275-+
[9]   Tyr682 in the Intracellular Domain of APP Regulates Amyloidogenic APP Processing In Vivo [J].
Barbagallo, Alessia P. M. ;
Weldon, Richard ;
Tamayev, Robert ;
Zhou, Dawang ;
Giliberto, Luca ;
Foreman, Oded ;
D'Adamio, Luciano .
PLOS ONE, 2010, 5 (11)
[10]   The Conundrum of GSK3 Inhibitors: Is it the Dawn of a New Beginning? [J].
Bhat, Ratan V. ;
Andersson, Ulf ;
Andersson, Shalini ;
Knerr, Laurent ;
Bauer, Udo ;
Sundgren-Andersson, Anna K. .
JOURNAL OF ALZHEIMERS DISEASE, 2018, 64 :S547-S554